Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

More Press Releases

Stocks fall as crude oil prices drop 4 percent; banks climb

Jul 16, 2018

NEW YORK — Major U.S. indexes closed mostly lower Monday as investors bought banks but sold most other types of stocks, including health care and technology companies. Energy stocks sank along with oil prices. Oil prices fell more than 4 percent after U.S. officials suggested the U.S. will take a softer stance on countries that import oil from Iran after sanctions on Iran's energy sector go back into effect in November. Banks rose along with interest rates as well as a solid second-quarter report from Bank of America. A strong forecast gave Deutsche Bank its biggest gain in more than...

Markets Right Now: Stocks end mostly lower on Wall Street

Jul 16, 2018

NEW YORK — The latest on developments in financial markets (all times local): 4 p.m. Stocks are closing mostly lower on Wall Street as a steep drop in oil prices delivered a blow to energy companies. Hess slumped 4 percent Monday. Health care and technology companies also fell. Adobe Systems gave up 1.5 percent. Tribune Media plunged 16.7 percent after the Federal Communications Commission said it had concerns about its deal to be acquired by Sinclair. Major banks rose sharply, led by a 4.3 percent surge in Bank of America after it reported strong results. The S&P 500 index fell...

US pledges $6 million in new aid for Venezuelan migrants

Jul 16, 2018

CUCUTA, Colombia — The United States is pledging an additional $6 million in aid to help Colombia respond to the massive influx of Venezuelans fleeing their country's economic and humanitarian crisis. United States Agency for International Development Administrator Mark Green made the announcement Monday during a trip to the border city of Cucuta. About half of the new aid will go toward food for Venezuelan migrants while the other half will help Colombia provide medical services to those fleeing. In total the U.S. has provided $56 million to humanitarian groups and Latin American nations receiving Venezuelan migrants since the beginning...

China slowdown weighs on markets as Trump meets Putin

Jul 16, 2018

LONDON — A slowdown in Chinese economic growth weighed on global stock markets Monday as investors kept a close watch on a summit U.S. President Donald Trump with Russian President Vladimir Putin. KEEPING SCORE: In Europe, Germany's DAX fell 0.2 percent to 12,521 while the CAC 40 in France was down 0.4 percent at 5,409. The FTSE 100 index was 1.1 percent lower at 7,577. U.S. stocks were poised for a flat opening with Dow futures and the broader S&P 500 futures down 0.1 percent. CHINA GROWTH: China's economic growth slowed in the quarter ending in June to an annual...

Asian shares drift lower as China data, trade cast shadows

Jul 16, 2018

BANGKOK — Shares edged lower in Asia early Monday after China reported lackluster growth data in line with expectations. Geopolitical and trade tensions were weighing on sentiment despite gains last week on Wall Street. KEEPING SCORE: The Shanghai Composite index lost 0.4 percent to 2,820.52 and Hong Kong's Hang Seng edged less than 0.1 percent lower to 28,486.70. The Kospi in South Korea fell 0.2 percent to 2,307.06 and Australia's S&P ASX 200 gave up 0.3 percent to 6,246.80. Shares fell in Southeast Asia and Taiwan. Japan's market was closed for a holiday. WALL STREET LAST WEEK: Stocks wrapped up...

Subscribe to our newsletter!

Your Name

Your Email Address